{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:46:33Z","timestamp":1777596393271,"version":"3.51.4"},"reference-count":43,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2019.7964","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T08:18:13Z","timestamp":1567153093000},"source":"Crossref","is-referenced-by-count":14,"title":["Pemphigus vulgaris - approach and management (Review)"],"prefix":"10.3892","author":[{"given":"Ioana","family":"Popescu","sequence":"first","affiliation":[{"name":"Department of Dermatology, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, Faculty of Medicine, 700115 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Statescu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, Faculty of Medicine, 700115 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Vata","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, Faculty of Medicine, 700115 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Andrese","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, Faculty of Medicine, 700115 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Patrascu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, Faculty of Medicine, 700115 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioana-Alina","family":"Grajdeanu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, Faculty of Medicine, 700115 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Solovastru","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, Faculty of Medicine, 700115 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,8,30]]},"reference":[{"key":"key20200713101613_b1-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1468-3083.2010.03753.x","article-title":"High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: A retrospective, bi-centre, comparative study","volume":"25","author":"Chaidemenos","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key20200713101613_b2-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1875-595X.2003.tb00654.x","article-title":"Case report: Oral pemphigus vulgaris with multiple oral polyps in a young patient","volume":"53","author":"Burgan","year":"2003","journal-title":"Int Dent J"},{"key":"key20200713101613_b3-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/archderm.1942.01500180020004","article-title":"Pemphigus: A historical study","volume":"46","author":"Lever","year":"1942","journal-title":"Arch Derm Syphilol"},{"key":"key20200713101613_b4-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00403-014-1531-1","article-title":"Geographic variations in epidemiology of two autoimmune bullous diseases: Pemphigus and bullous pemphigoid","volume":"307","author":"Alpsoy","year":"2015","journal-title":"Arch Dermatol Res"},{"key":"key20200713101613_b5-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2340\/00015555-1854","article-title":"Development of a disease registry for autoimmune bullous diseases: Initial analysis of the pemphigus vulgaris subset","volume":"95","author":"Shah","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"key20200713101613_b6-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.clindermatol.2011.01.015","article-title":"Oral involvement in autoimmune bullous diseases","volume":"29","author":"Ramos-e-Silva","year":"2011","journal-title":"Clin Dermatol"},{"key":"key20200713101613_b7-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1056\/NEJMra061111","article-title":"Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome","volume":"355","author":"Stanley","year":"2006","journal-title":"N Engl J Med"},{"key":"key20200713101613_b8-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3109\/08916934.2011.606444","article-title":"Pemphigus autoimmunity: Hypotheses and realities","volume":"45","author":"Grando","year":"2012","journal-title":"Autoimmunity"},{"key":"key20200713101613_b9-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/j.1600-0625.2009.00934.x","article-title":"Apoptolysis: A novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis","volume":"18","author":"Grando","year":"2009","journal-title":"Exp Dermatol"},{"key":"key20200713101613_b10-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/exd.13106","article-title":"Monopathogenic vs multipathogenic explanations of pemphigus pathophysiology","volume":"25","author":"Ahmed","year":"2016","journal-title":"Exp Dermatol"},{"key":"key20200713101613_b11-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00403-007-0760-y","article-title":"Circulating pemphigus autoantibodies in healthy relatives of pemphigus patients: Coincidental phenomenon with a risk of disease development?","volume":"299","author":"Torzecka","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"key20200713101613_b12-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.clindermatol.2013.01.005","article-title":"Pemphigus: associations and management guidelines: facts and controversies","volume":"31","author":"Ruocco","year":"2013","journal-title":"Clin Dermatol"},{"key":"key20200713101613_b13-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3389\/fmed.2018.00226","article-title":"The genetics of pemphigus vulgaris","volume":"5","author":"Vodo","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"key20200713101613_b14-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.clindermatol.2013.01.004","article-title":"Pemphigus: etiology, pathogenesis, and inducing or triggering factors: facts and controversies","volume":"31","author":"Ruocco","year":"2013","journal-title":"Clin Dermatol"},{"key":"key20200713101613_b15-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1074\/jbc.M110.172874","article-title":"p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris","volume":"286","author":"Mao","year":"2011","journal-title":"J Biol Chem"},{"key":"key20200713101613_b16-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"e50696","DOI":"10.1371\/journal.pone.0050696","article-title":"Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation","volume":"7","author":"Saito","year":"2012","journal-title":"PLoS One"},{"issue":"pii","key":"key20200713101613_b17-etm-0-0-7964","first-page":"F1000","article-title":"Recent advances in the understanding and treatment of pemphigus and pemphigoid","author":"Yamagami","year":"2018","journal-title":"F1000Res"},{"key":"key20200713101613_b18-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3389\/fmed.2018.00296","article-title":"Diagnosis of autoimmune blistering diseases","volume":"5","author":"Witte","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"key20200713101613_b19-etm-0-0-7964","first-page":"1","volume-title":"Autoimmune Bullous Diseases","author":"Shoimer","year":"2016"},{"key":"key20200713101613_b20-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/jid.2014.291","article-title":"Persistence of anti-desmoglein 3 IgG(+) B-cell clones in pemphigus patients over years","volume":"135","author":"Hammers","year":"2015","journal-title":"J Invest Dermatol"},{"key":"key20200713101613_b21-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ijwd.2017.10.001","article-title":"New biochip immunofluorescence test for the serological diagnosis of pemphigus vulgaris and foliaceus: A review of the literature","volume":"4","author":"Xuan","year":"2018","journal-title":"Int J Womens Dermatol"},{"key":"key20200713101613_b22-etm-0-0-7964","first-page":"4102","article-title":"Current and future applications of confocal laser scanning microscopy imaging in skin oncology","volume":"17","author":"Ilie","year":"2019","journal-title":"Oncol Lett"},{"key":"key20200713101613_b23-etm-0-0-7964","first-page":"1004","article-title":"In vivo confocal laser scanning microscopy imaging of skin inflammation: Clinical applications and research directions","volume":"17","author":"Ilie","year":"2019","journal-title":"Exp Ther Med"},{"key":"key20200713101613_b24-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(05)66829-8","article-title":"Pemphigus","volume":"366","author":"Bystryn","year":"2005","journal-title":"Lancet"},{"key":"key20200713101613_b25-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/TCRM.S142471","article-title":"Emerging treatment options for the management of pemphigus vulgaris","volume":"14","author":"Kridin","year":"2018","journal-title":"Ther Clin Risk Manag"},{"key":"key20200713101613_b26-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/bjd.15930","article-title":"British Association of Dermatologists' guidelines for the management of pemphigus vulgaris","volume":"177","author":"Harman","year":"2017","journal-title":"Br J Dermatol"},{"key":"key20200713101613_b27-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/1346-8138.12486","article-title":"Japanese guidelines for the management of pemphigus","volume":"41","author":"Amagai","year":"2014","journal-title":"J Dermatol"},{"key":"key20200713101613_b28-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/jdv.12772","article-title":"Pemphigus. S2 Guideline for diagnosis and treatment - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)","volume":"29","author":"Hertl","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key20200713101613_b29-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2016.02.1240","article-title":"Prevention and management of glucocorticoid-induced side effects: A comprehensive review: A review of glucocorticoid pharmacology and bone health","volume":"76","author":"Caplan","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"key20200713101613_b30-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jaad.2013.05.016","article-title":"Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids","volume":"69","author":"Almugairen","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"key20200713101613_b31-etm-0-0-7964","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1468-3083.2012.04717.x","article-title":"Randomized double blind trial of prednisolone and azathioprine, vs. prednisolone and placebo, in the treatment of pemphigus vulgaris","volume":"27","author":"Chams-Davatchi","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key20200713101613_b32-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1038\/jid.2010.91","article-title":"Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: A multicenter, randomized, placebo-controlled trial","volume":"130","author":"Beissert","year":"2010","journal-title":"J Invest Dermatol"},{"key":"key20200713101613_b33-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1590\/abd1806-4841.2019940206","article-title":"Consensus on the treatment of autoimmune bullous dermatoses: Pemphigus vulgaris and pemphigus foliaceus - Brazilian Society of Dermatology","volume":"94","author":"Porro","year":"2019","journal-title":"An Bras Dermatol"},{"key":"key20200713101613_b34-etm-0-0-7964","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1684\/ejd.2011.1611","article-title":"Methotrexate is an effective and safe adjuvant therapy for pemphigus vulgaris","volume":"22","author":"Baum","year":"2012","journal-title":"Eur J Dermatol"},{"key":"key20200713101613_b35-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2165\/00128071-200708020-00004","article-title":"Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris","volume":"8","author":"Olszewska","year":"2007","journal-title":"Am J Clin Dermatol"},{"key":"key20200713101613_b36-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/S0140-6736(17)30070-3","article-title":"First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): A prospective, multicentre, parallel-group, open-label randomised trial","volume":"389","author":"Joly","year":"2017","journal-title":"Lancet"},{"key":"key20200713101613_b37-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jaad.2008.09.052","article-title":"A randomized double-blind trial of intravenous immunoglobulin for pemphigus","volume":"60","author":"Amagai","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"key20200713101613_b38-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"e12601","DOI":"10.1111\/aji.12601","article-title":"Management of pemphigus disease in pregnancy","volume":"77","author":"Tavakolpour","year":"2017","journal-title":"Am J Reprod Immunol"},{"key":"key20200713101613_b39-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1001\/archderm.124.11.1659","article-title":"Controlled study of plasma exchange in pemphigus","volume":"124","author":"Guillaume","year":"1988","journal-title":"Arch Dermatol"},{"key":"key20200713101613_b40-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/jdv.12175","article-title":"Treatment of severe autoimmune blistering skin diseases with combination of protein A immunoadsorption and rituximab: A protocol without initial high dose or pulse steroid medication","volume":"28","author":"Kolesnik","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key20200713101613_b41-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1365-2133.2011.10585.x","article-title":"Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine\/mycophenolate mofetil: A pilot study of 23 patients","volume":"166","author":"Kasperkiewicz","year":"2012","journal-title":"Br J Dermatol"},{"key":"key20200713101613_b42-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1001\/jamadermatol.2014.1939","article-title":"Subcutaneous veltuzumab, a humanized anti-CD20 antibody, in the treatment of refractory pemphigus vulgaris","volume":"150","author":"Ellebrecht","year":"2014","journal-title":"JAMA Dermatol"},{"key":"key20200713101613_b43-etm-0-0-7964","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1126\/science.aaf6756","article-title":"Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease","volume":"353","author":"Ellebrecht","year":"2016","journal-title":"Science"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T19:46:57Z","timestamp":1721677617000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2019.7964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,30]]},"references-count":43,"URL":"https:\/\/doi.org\/10.3892\/etm.2019.7964","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,30]]}}}